What Works When Treating Granulomatous Disease in Genetically Undefined CVID? A Systematic Review

BACKGROUND: Granulomatous disease is reported in at least 8–20% of patients with common variable immunodeficiency (CVID). Granulomatous disease mainly affects the lungs, and is associated with significantly higher morbidity and mortality. In half of patients with granulomatous disease, extrapulmonar...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Immunol
Main Authors: van Stigt, Astrid C., Dik, Willem A., Kamphuis, Lieke S. J., Smits, Bas M., van Montfrans, Joris M., van Hagen, P. Martin, Dalm, Virgil A. S. H., IJspeert, Hanna
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7773704/
https://ncbi.nlm.nih.gov/pubmed/33391274
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.606389
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados